Oxidative Stress in Patients with End-Stage Renal Disease prior to the Start of Renal Replacement Therapy

Publisher： Karger

E-ISSN： 1660-2110|98|1|c3-c7

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.98, Iss.1, 2004-11, pp. : c3-c7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidiabetic Therapy in End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 337-344

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parenteral Iron Therapy in Treatment of Anemia in End-Stage Renal Disease Patients: A Comparative Study between Iron Saccharate and Gluconate

By  

Nephron Clin Pract, Vol. 99, Iss. 4, 2005-02 ,pp. : c97-c101

Karger

Access to resources Recommend Favorite

Bicarbonate Therapy in End‐Stage Renal Disease: Current Practice Trends and Implications

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 370-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of Prostate Cancer in End-Stage Renal Disease Patients

By  

Urologia Internationalis, Vol. 80, Iss. 4, 2008-06 ,pp. : 419-424

Karger

Access to resources Recommend Favorite